Long-term follow-up from the phase 1/2 MajesTEC-1 trial of teclistamab in patients with relapsed/refractory multiple myeloma

被引：0

作者：

Garfall, Alfred L.

Nooka, Ajay K.

van de Donk, Niels W. C. J.

Moreau, Philippe

Bhutani, Manisha

Oriol, Albert

Martin, Thomas G.

Rosinol, Laura

Mateos, Maria-Victoria

Bahlis, Nizar J.

Popat, Rakesh

Besemer, Britta

Martinez-Lopez, Joaquin

Krishnan, Amrita Y.

Delforge, Michel

Huang, Lin

Vishwamitra, Deeksha

Stephenson, Tara

Chastain, Katherine

Sidana, Surbhi

机构：

[1] Penn Med Abramson Canc Ctr, Philadelphia, PA USA

[2] Emory Univ, Winship Canc Inst, Atlanta, GA USA

[3] Vrije Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam, Netherlands

[4] Univ Hosp Hotel Dieu, Hematol Clin, Nantes, France

[5] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA

[6] Hosp Badalona Germans Trias & Pujol, Inst Catal Oncol, Badalona, Spain

[7] Hosp Badalona Germans Trias & Pujol, Inst Josep Carreras, Badalona, Spain

[8] Univ Calif San Francisco, San Francisco, CA USA

[9] IDIBAPS, Hosp Clin Barcelona, Barcelona, Spain

[10] Hosp Univ Salamanca, Inst Invest Biomed Salamanca IBSAL, Centro Invest Canc IBMCC USAL, CSIC, Salamanca, Spain

[11] Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada

[12] Univ Coll London Hosp, NHS Fdn Trust, London, England

[13] Univ Hosp Tubingen, Tubingen, Germany

[14] Hosp 12 Octubre, Hematol, Madrid, Spain

[15] City Hope Comprehens Canc Ctr, Duarte, CA USA

[16] Univ Leuven, Leuven, Belgium

[17] Johnson & Johnson Innovat Med, Spring House, PA USA

[18] Johnson & Johnson Innovat Med, Raritan, NJ USA

[19] Stanford Univ, Sch Med, Stanford, CA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

7540

引用

页数：1